Navigation Links
Bunge Responds to Syngenta Suit

ST. LOUIS, Aug. 23, 2011 /PRNewswire/ -- Bunge North America, the North American operating arm of Bunge Limited (NYSE: BG), issued the following statement which can be attributed to Soren Schroder, Bunge North America president and CEO.

"Bunge North America is aware from press reports of Syngenta's allegations.  From what we know and from prior conversations with Syngenta, we are surprised and disappointed that Syngenta has taken an action which could put at risk a major export market for U.S. corn producers -- China.

Bunge is a strong proponent of agricultural biotechnology and the benefits it offers to the entire value chain.  We have communicated to Syngenta on several occasions that Bunge looks forward to accepting Agrisure® Viptera™ once approval from China is secured.  We understand that Syngenta expects this will happen in early 2012.

However, until this approval occurs, we must protect the integrity of our export supply chain by not accepting Agrisure Viptera and other varieties that do not have major export market approval.  Our obligation to our farmer customers is to provide access to the global marketplace and the price benefits of that access.  Syngenta's decision to commercialize Agrisure Viptera should not foreclose our ability to sell to a major market – China.

Bunge's decision not to accept Agrisure Viptera is consistent with the North American Export Grain Association's (NAEGA) policy to advocate that technology providers receive all major international approvals for a trait prior to seed sales.  The grain export industry, which includes Bunge, notified Syngenta more than a year ago that China is considered a major export market.

According to the U.S. Department of Agriculture, China is currently the seventh largest destination for U.S. corn with imports expected to grow significantly this year."

SOURCE Bunge North America
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. SG Biofuels and Bunge Form Strategic Alliance to Process Jatropha Seeds Into Sustainable Crude Oil
2. Bunge Limited to Expand Sugar and Bioenergy Business in Brazil
3. Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
4. HCCS Responds to Recent Tornados, Earthquakes and Flooding With Free Online Training Course for Disaster Preparedness
5. Virtual reality helps researchers track how brain responds to surroundings
6. Burrill & Company Responds to Recent Press Coverage About Biopark Investment at Elk Run
7. China Biologic Products Responds to Allegations on Financial Websites
8. Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification
9. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
10. Viral Genetics Responds to Rumors of Imminent FDA Filing and Third Party Press Releases
11. Immucor Responds To FDA Notice
Post Your Comments:
(Date:10/10/2017)... Oct. 10, 2017 SomaGenics announced the receipt ... to develop RealSeq®-SC (Single Cell), expected to be the ... RNAs (including microRNAs) from single cells using NGS methods. ... need to accelerate development of approaches to analyze the ... "New techniques for measuring levels of mRNAs in ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... ... recipients of 13 prestigious awards honoring scientists who have made ... in a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition ...
(Date:10/9/2017)... Jupiter, FL (PRWEB) , ... October 09, 2017 , ... ... episode, scheduled to broadcast first quarter 2018. American Farmer airs Tuesdays at 8:30aET on ... Agriculture industry is faced with the challenge of how to continue to feed a ...
(Date:10/9/2017)... , ... October 09, 2017 , ... ... four-tiered line of medical marijuana products targeting the needs of consumers who are ... of Kindred takes place in Phoenix, Arizona. , As operators of two successful ...
Breaking Biology Technology:
(Date:4/13/2017)... 2017 According to a new market research report ... Identity Administration, and Authorization), Service, Authentication Type, Deployment Mode, Vertical, and Region ... expected to grow from USD 14.30 Billion in 2017 to USD 31.75 ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... April 6, 2017 Forecasts by ... Document Readers, by End-Use (Transportation & Logistics, Government & ... Gas & Fossil Generation Facility, Nuclear Power), Industrial, Retail, ... Are you looking for a definitive report ... ...
(Date:4/3/2017)... 2017  Data captured by IsoCode, IsoPlexis ... a statistically significant association between the potency ... and objective response of cancer patients post-treatment. ... whether cancer patients will respond to CAR-T ... as to improve both pre-infusion potency testing and ...
Breaking Biology News(10 mins):